The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions

被引:79
|
作者
Shams, Shahin [1 ]
Martinez, Joseph M. [2 ]
Dawson, John R. D. [3 ]
Flores, Juan [4 ]
Gabriel, Marina [1 ]
Garcia, Gustavo [1 ]
Guevara, Amanda [2 ]
Murray, Kaitlin [5 ]
Pacifici, Noah [1 ]
Vargas, Maxemiliano V. [6 ]
Voelker, Taylor [3 ]
Hell, Johannes W. [2 ]
Ashouri, Judith F. [7 ]
机构
[1] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA
[2] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA
[3] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA
[4] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA
[5] Univ Calif Davis, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA
[6] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA
[7] Univ Calif San Francisco, Dept Med, Rosalind Russell & Ephraim R Engleman Rheumatol R, San Francisco, CA 94143 USA
来源
FRONTIERS IN PHARMACOLOGY | 2021年 / 12卷
基金
新加坡国家研究基金会;
关键词
rheumatoid arthritis; autoimmune disease; inflammatory cytokines and chemokines; adenosine receptor; JAK-STAT signaling; biological therapies; disease modifying anti-rheumatic drugs; nanoparticles; LOW-DOSE METHOTREXATE; NECROSIS-FACTOR-ALPHA; INTERLEUKIN-1 RECEPTOR ANTAGONIST; COLLAGEN-INDUCED ARTHRITIS; T-CELL-ACTIVATION; MODIFYING ANTIRHEUMATIC DRUGS; MESENCHYMAL STEM-CELLS; DOUBLE-BLIND; IN-VIVO; COMBINATION THERAPY;
D O I
10.3389/fphar.2021.680043
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Rheumatoid arthritis (RA) is a debilitating autoimmune disease with grave physical, emotional and socioeconomic consequences. Despite advances in targeted biologic and pharmacologic interventions that have recently come to market, many patients with RA continue to have inadequate response to therapies, or intolerable side effects, with resultant progression of their disease. In this review, we detail multiple biomolecular pathways involved in RA disease pathogenesis to elucidate and highlight pathways that have been therapeutic targets in managing this systemic autoimmune disease. Here we present an up-to-date accounting of both emerging and approved pharmacological treatments for RA, detailing their discovery, mechanisms of action, efficacy, and limitations. Finally, we turn to the emerging fields of bioengineering and cell therapy to illuminate possible future targeted therapeutic options that combine material and biological sciences for localized therapeutic action with the potential to greatly reduce side effects seen in systemically applied treatment modalities.
引用
收藏
页数:27
相关论文
共 50 条
  • [41] Current and future pharmaceutical therapy for rheumatoid arthritis
    Ruderman, EM
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (05) : 671 - 684
  • [42] Current standards and future treatments of rheumatoid arthritis
    Onysko, Mary
    Burch, Jessica
    FORMULARY, 2012, 47 (10) : 359 - +
  • [43] Current and future management approaches for rheumatoid arthritis
    Ferdinand C Breedveld
    Arthritis Research & Therapy, 4 (Suppl 2)
  • [44] EPIDEMIOLOGIC STUDIES OF RHEUMATOID-ARTHRITIS - FUTURE-DIRECTIONS
    HEATH, CW
    FORTIN, PR
    JOURNAL OF RHEUMATOLOGY, 1992, 19 : 74 - 79
  • [45] Adrenocortical dysfunction in rheumatoid arthritis: Α narrative review and future directions
    Filippa, Maria G.
    Tektonidou, Maria G.
    Mantzou, Aimilia
    Kaltsas, Gregory A.
    Chrousos, George P.
    Sfikakis, Petros P.
    Yavropoulou, Maria P.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2022, 52 (01)
  • [46] Identification of patients with early rheumatoid arthritis: Challenges and future directions
    Orozco, Catalina
    Olsen, Nancy J.
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2006, 13 (2-4): : 295 - 297
  • [47] Preclinical Rheumatoid Arthritis: Identification, Evaluation, and Future Directions for Investigation
    Deane, Kevin D.
    Norris, Jill M.
    Holers, V. Michael
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2010, 36 (02) : 213 - +
  • [48] Global Landscape of Benefit-Risk Considerations for Medicinal Products: Current State and Future Directions
    Waschbusch, Max
    Rodriguez, Lisa
    Brueckner, Andreas
    Lee, Kerry Jo
    Li, Xuefeng
    Mokliatchouk, Oksana
    Tremmel, Lothar
    Yuan, Shuai S.
    PHARMACEUTICAL MEDICINE, 2022, 36 (04) : 201 - 213
  • [49] Angiogenesis in rheumatoid arthritis: implications for future therapeutic strategies
    Paleolog, EM
    Fava, RA
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1998, 20 (1-2): : 73 - 94
  • [50] Current State and Future Directions in the Therapy of ALS
    Tzeplaeff, Laura
    Wilfling, Sibylle
    Requardt, Maria Viktoria
    Herdick, Meret
    CELLS, 2023, 12 (11)